The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
Avoidance of apoptosis is a key mechanism that malignancies, including acute leukemias and MDS, utilize in order to proliferate and resist chemotherapy. Recently, venetoclax, an inhibitor of the anti-apoptotic protein BCL-2, has been approved for the treatment of upfront AML in an unfit, elderly pop...
| Published in: | Frontiers in Oncology |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-03-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00192/full |
